Barclays’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.05M | Buy |
320,490
+89,266
| +39% | +$850K | ﹤0.01% | 1954 |
|
|
2025
Q1 | $2.42M | Buy |
231,224
+38,985
| +20% | +$408K | ﹤0.01% | 1902 |
|
|
2024
Q4 | $4.53M | Sell |
192,239
-15,070
| -7% | -$355K | ﹤0.01% | 1671 |
|
|
2024
Q3 | $7.45M | Buy |
207,309
+128,246
| +162% | +$4.61M | ﹤0.01% | 1216 |
|
|
2024
Q2 | $2.79M | Sell |
79,063
-4,909
| -6% | -$173K | ﹤0.01% | 1486 |
|
|
2024
Q1 | $2.38M | Sell |
83,972
-69,379
| -45% | -$1.97M | ﹤0.01% | 1825 |
|
|
2023
Q4 | $2.04M | Buy |
153,351
+53,777
| +54% | +$715K | ﹤0.01% | 2151 |
|
|
2023
Q3 | $892K | Buy |
99,574
+17,603
| +21% | +$158K | ﹤0.01% | 2168 |
|
|
2023
Q2 | $922K | Buy |
81,971
+49,883
| +155% | +$561K | ﹤0.01% | 2211 |
|
|
2023
Q1 | $370K | Buy |
32,088
+7,845
| +32% | +$90.5K | ﹤0.01% | 2835 |
|
|
2022
Q4 | $282K | Buy |
24,243
+7,164
| +42% | +$83.3K | ﹤0.01% | 2926 |
|
|
2022
Q3 | $217K | Sell |
17,079
-62,420
| -79% | -$793K | ﹤0.01% | 3032 |
|
|
2022
Q2 | $547K | Buy |
79,499
+60,313
| +314% | +$415K | ﹤0.01% | 2505 |
|
|
2022
Q1 | $185K | Buy |
+19,186
| New | +$185K | ﹤0.01% | 3359 |
|